FDA Inspection
ExcelvisionExcelvision – FDA Inspection, Nov 19, 2024
Record Details
This FDA Inspection record concerns Excelvision, with an inspection on November 19, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 1c04fdce-a8c8-4aaa-8e34-af6be8775bba
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1254548
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Excelvision
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 22, 2026 | OAI | Office of Inspections and Investigations | Drug Quality Assurance |
| July 7, 2023 | VAI | Drug Quality Assurance | |
| October 23, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 8, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 10, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Excelvision
- FDA Inspection 1297654 - 2026-01-22
- FDA Inspection 1209561 - 2023-07-07
- FDA Inspection 1203732 - 2020-10-23
- FDA Inspection 1062425 - 2017-12-08
- FDA Inspection 914665 - 2015-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.